Science Explorer Interactive view Map
Company · Leiden · Netherlands

Astellas Pharma (Netherlands)

In research, Astellas Pharma (Netherlands) stands highest in Medicine (#10,473 of 17,978 worldwide) and Health Sciences (#13,585 of 20,462 worldwide), over all time.

astellas.com/en/index.htmlROR OpenAlex
World rank, all time
#28,538
of 42,892
Rank in Netherlands
#340
of 464
Research works
200
▼ 38% vs 2013–17
Citations
4.7k
23.5 per fractional work
Top-10% rate
12.4%
record average 16.5%
Open access
43%
world 28%

What is Astellas Pharma (Netherlands) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #10,473 of 17,978 28.2%134
Health SciencesDomain #13,585 of 20,462 28.0%137

Each strip is that field’s whole ranked pool, with the notch where Astellas Pharma (Netherlands) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.52× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.82× its world share, 1 worksImmunology and Micro…Neuroscience: 0.66× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.39× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.29× its world share, 0 worksComputer ScienceEngineering: 0.02× its world share, 0 worksEngineeringEnvironmental Science: 0.13× its world share, 0 worksEnvironmental ScienceMathematics: 2.83× its world share, 1 worksMathematicsPhysics and Astronomy: 0.09× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.66× its world share, 0 worksHealth ProfessionsMedicine: 3.21× its world share, 11 worksMedicineBusiness, Management and Accounting: 0.14× its world share, 0 worksBusiness, Management…Decision Sciences: 0.69× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.44× its world share, 1 worksEconomics, Econometr…Psychology: 1.56× its world share, 1 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.8×. Every wedge is a field page.

Who are the top researchers at Astellas Pharma (Netherlands)?

Ranked on the composite score, Stefan Holmström, Floortje van Nooten and Katharina Modelska lead among researchers whose main affiliation is Astellas Pharma (Netherlands).

  1. 1 Stefan Holmström Netherlands · #1,329,332 worldwide 18 citations · 22 works
  2. 2 Floortje van Nooten Netherlands · #1,359,700 worldwide 14 citations · 16 works
  3. 3 Katharina Modelska Netherlands · #1,617,566 worldwide 8 citations · 15 works
All ranked researchers at Astellas Pharma (Netherlands)

Which keywords describe research at Astellas Pharma (Netherlands)?

By fractional works in all years, weighted toward what it does more of than the world: Urinary Incontinence, Quality of Life, Epidemiology, Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms, Cardiovascular Disease, Immunotherapy and Hormone Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology28▲ 3.5×44 topics
  2. Urinary Incontinence25▲ 138×2 topics
  3. Quality of Life21▲ 8.0×11 topics
  4. Benign Prostatic Hyperplasia17▲ 207×1 topic
  5. Lower Urinary Tract Symptoms17▲ 207×1 topic
  6. Cardiovascular Disease15▲ 6.8×17 topics
  7. Immunotherapy11▲ 8.7×12 topics
  8. Hormone Therapy11▲ 52×3 topics
  9. Biomarkers11▲ 8.8×9 topics
  10. Cancer Treatment10▲ 20×4 topics
  11. Chronic Kidney Disease10▲ 21×5 topics
  12. Prostate Cancer10▲ 33×4 topics
  13. Surgical Treatment10▲ 24×3 topics
  14. Heart Failure9▲ 10×6 topics
  15. Clinical Trials9▲ 7.3×10 topics
  16. Stroke9▲ 28×4 topics
  17. Neuroprotection9▲ 11×6 topics
  18. Anemia8▲ 37×3 topics
  19. Antimicrobial Resistance8▲ 16×4 topics
  20. Rehabilitation8▲ 11×4 topics
  21. Pelvic Floor Dysfunction8▲ 81×1 topic
  22. Pelvic Organ Prolapse8▲ 81×1 topic
  23. Iron Deficiency8▲ 69×2 topics
  24. Treatment Guidelines8▲ 18×3 topics
  25. Catheter-Associated Infections7▲ 104×1 topic
  26. Urinary Tract Infections7▲ 81×1 topic
  27. Guidelines7▲ 7.2×6 topics
  28. Genetic Mutations7▲ 6.4×5 topics
  29. Metabolic Syndrome7▲ 3.9×12 topics
  30. Erythropoiesis-Stimulating Agents6▲ 223×1 topic
  31. Genomic Profiling6▲ 33×2 topics
  32. Hypoxia-Inducible Factors6▲ 223×1 topic
  33. Androgen Receptor6▲ 34×1 topic
  34. Metastatic Prostate Cancer6▲ 71×1 topic
  35. Chemotherapy6▲ 4.1×10 topics
  36. Cost-effectiveness Analysis6▲ 37×1 topic
  37. Health Utility Measures6▲ 37×1 topic
  38. Diabetes5▲ 5.3×11 topics
  39. Clinical Guidelines5▲ 8.5×7 topics
  40. Nociception5▲ 36×2 topics

Which research topics does Astellas Pharma (Netherlands) publish most on?

By volume in 2022–2025: BRCA gene mutations in cancer, Menopause: Health Impacts and Treatments, Erythropoietin and Anemia Treatment and Health Systems, Economic Evaluations, Quality of Life.

BRCA gene mutations in c…1BRCA gene mutations in cancer: 1 fractional worksMenopause: Health Impact…1Menopause: Health Impacts and Treatments: 1 fractional worksErythropoietin and Anemi…1Erythropoietin and Anemia Treatment: 1 fractional worksHealth Systems, Economic…1Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksBladder and Urothelial Cancer Treatments: 1 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksHormonal and reproductiv…0Hormonal and reproductive studies: 0 fractional worksAcute Myeloid Leukemia Research: 0 fractional worksSexual function and dysfunction studies: 0 fractional worksUrinary Bladder and Prostate Research: 0 fractional works
GeneticsEndocrinology, Diabetes and MetabolismHematologyEconomics and Econometrics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 BRCA gene mutations in cancer Genetics 1 works
  2. 2 Menopause: Health Impacts and Treatments Endocrinology, Diabetes and Metabolism 1 works
  3. 3 Erythropoietin and Anemia Treatment Hematology 1 works
  4. 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  5. 5 Bladder and Urothelial Cancer Treatments Surgery 1 works
  6. 6 Biosimilars and Bioanalytical Methods Immunology 0 works
  7. 7 Hormonal and reproductive studies Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Acute Myeloid Leukemia Research Hematology 0 works
  9. 9 Sexual function and dysfunction studies Psychiatry and Mental health 0 works
  10. 10 Urinary Bladder and Prostate Research Urology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.8%not open57.2%

World: 28% of research is openly available.

with international co-authors76.1%domestic only23.9%

World: 19% is written across borders.

How has Astellas Pharma (Netherlands)'s research output changed?

Output in 2018–2022 was 38% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Leiden

All research institutions in Leiden

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.